ipratropium
Commercial- Indications
- Respiratory diseases
Company intelligence / Profile preview
JAMP Pharma
Boucherville, Quebec, Canadajamppharma.ca ↗
- Ownership
- Private
- Employees
- ~610
- Development stage
- Commercial
01
Overview
JAMP Pharma Group has a commercial-stage portfolio with more than 325–345 molecules across generics and specialty drugs. It leads the Canadian market in product launches with over 130 new Health Canada approvals in the past three years. The company recently launched PrJamtekiTM—the first ustekinumab biosimilar approved in Canada—and PrJAMP Ipratropium HFA as the only generic alternative to Atrovent® HFA. The company also acquired a manufacturing facility in Lévis to strengthen local production capacity.
- Therapeutic areas
- OtherPulmonologyImmunology
- Modalities
- Small molecules (generics)biosimilars (e.g., monoclonal antibodies like ustekinumab)branded drugsover-the-counter health products
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Alvotech—exclusive partnership for development of biosimilars including JamtekiTM/ustekinumab
Beyond the preview
Go deeper on JAMP Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JAMP Pharma.